- Clinical Trials
- April 2024
- 60 Pages
Global
From €1439EUR$1,500USD£1,245GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1199EUR$1,250USD£1,037GBP
- Report
- August 2023
- 201 Pages
Global
From €7196EUR$7,500USD£6,223GBP
- Report
- October 2023
- 182 Pages
Global
From €4701EUR$4,900USD£4,065GBP
- Report
- October 2019
- 90 Pages
Global
From €5709EUR$5,950USD£4,937GBP
- Report
- October 2022
- 113 Pages
Global
From €4558EUR$4,750USD£3,941GBP
- Report
- March 2023
- 117 Pages
Global
From €4701EUR$4,900USD£4,065GBP
- Report
- August 2022
- 105 Pages
Global
From €4558EUR$4,750USD£3,941GBP
- Report
- February 2023
- 120 Pages
Global
From €7196EUR$7,500USD£6,223GBP
- Report
- October 2022
- 120 Pages
Global
From €4318EUR$4,500USD£3,734GBP
- Report
- March 2021
- 100 Pages
Global
From €4318EUR$4,500USD£3,734GBP
- Report
- July 2021
- 50 Pages
China
From €2495EUR$2,600USD£2,157GBP
- Report
- May 2021
- 42 Pages
Global
€1265EUR$1,318USD£1,094GBP
- Report
- September 2021
- 126 Pages
Global
From €10550EUR$10,995USD£9,122GBP
- Report
- November 2020
- 225 Pages
Global
From €10550EUR$10,995USD£9,122GBP
- Drug Pipelines
- October 2020
- 39 Pages
Global
From €3358EUR$3,500USD£2,904GBP
- Drug Pipelines
- September 2020
- 96 Pages
Global
From €1919EUR$2,000USD£1,659GBP
- Drug Pipelines
- September 2018
- 64 Pages
Global
From €3358EUR$3,500USD£2,904GBP
- Drug Pipelines
- September 2018
- 30 Pages
Global
From €3358EUR$3,500USD£2,904GBP
- Report
- December 2023
- 73 Pages
Global
From €3500EUR$3,908USD£3,132GBP
Somatostatin is a peptide hormone that is used in the treatment of various types of cancer. It is used to inhibit the release of growth hormones, which can help reduce the size of tumors. It is also used to reduce the side effects of chemotherapy and radiation therapy. Somatostatin is available in both injectable and oral forms. It is often used in combination with other drugs to treat cancer.
Somatostatin is used to treat a variety of cancers, including pancreatic, prostate, and neuroendocrine tumors. It is also used to treat acromegaly, a condition caused by excessive growth hormone production. Somatostatin is also used to treat Cushing's syndrome, a condition caused by excessive cortisol production.
Some companies that produce somatostatin include Novartis, Merck, and Pfizer. Other companies that produce somatostatin-based drugs include Ipsen, Teva, and Sandoz. Show Less Read more